CLINICAL RESPONSES BY BASELINE RA DISEASE DURATION IN THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA PATIENTS WITH BACKGROUND METHOTREXATE) TRIAL: 2-YEAR RESULTS